Agios Pharmaceuticals | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
AbbVie USD 610M 19M 2024-12
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amgen USD 723M 24M 2025-03
Arrowhead Research USD 21.65M 7M 2024-12
Astellas Pharma 3.91B 320M 2025-03
AstraZeneca 429M 28M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Daiichi Sankyo 7.08B 4.54B 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Exelixis 23.4M 3.9M 2023-09
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Merck USD 313M 15M 2025-03
Moderna USD 1000K 5M 2025-03
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Agios Pharmaceuticals Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.